|
|
| | Parecoxib Impurity H Basic information |
| Product Name: | Parecoxib Impurity H | | Synonyms: | Parecoxib Impurity H;Parecoxib Sodium Imp.H;Parecoxib SodiuM iMpurity J;Parecoxib Sodium Impurity L;Parecoxib Sodium impurity Y;Parecoxib-005;Valdecoxib Disulfonamide Impurity (Parecoxib Impurity 1);N-[[3-[5-methyl-4-[4-[[(1-oxopropyl)amino]sulfonyl]phenyl]-3-isoxazolyl]phenyl]sulfonyl]-Propanamide | | CAS: | 1708094-99-8 | | MF: | C22H23N3O7S2 | | MW: | 505.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1708094-99-8.mol |  |
| | Parecoxib Impurity H Chemical Properties |
| density | 1.352±0.06 g/cm3(Predicted) | | pka | 5.03±0.10(Predicted) |
| | Parecoxib Impurity H Usage And Synthesis |
| Uses | N-((4-(5-Methyl-3-(3-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide is a reagent for the synthesis of Parecoxib Sodium Impurity. Also an Impurity of Parecoxib Sodium (P193275), which is an analgesic and an anti-inflammatory agent. |
| | Parecoxib Impurity H Preparation Products And Raw materials |
|